
Cuprina Holdings (cayman) Ltd.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Stock Performance (90 Days)
Layoff History
Recent News
Other Medical Instruments & Supplies Companies
View All →Frequently Asked Questions
Has Cuprina Holdings (Cayman) LTD had layoffs?
How many employees does Cuprina Holdings (Cayman) LTD have?
What industry is Cuprina Holdings (Cayman) LTD in?
Is Cuprina Holdings (Cayman) LTD a publicly traded company?
Where is Cuprina Holdings (Cayman) LTD headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.